Growth hormone release inhibiting hormone: Neuropharmacological studies

Nicholas P. Plotnikoff, Abba J. Kastin, Andrew V. Schally

Research output: Contribution to journalArticlepeer-review

42 Scopus citations


Significant potentiation of the behavioral effects of DOPA were observed in mice pretreated with GH-RIH. In addition, a slight reduction of oxotremorine induced symptoms was seen. No significant effects of GH-RIH were observed in several other tests involving the central nervous system (CNS). The results support our concept of the CNS actions of peptides.

Original languageEnglish (US)
Pages (from-to)693-696
Number of pages4
JournalPharmacology, Biochemistry and Behavior
Issue number5
StatePublished - Jan 1 1974
Externally publishedYes


  • Aggression
  • Behavior
  • Central nervous system
  • DOPA
  • Growth hormone
  • Growth-hormone release inhibiting hormone
  • Hypothalamus
  • Oxotremorine
  • Pituitary
  • Seizures
  • Serotonin

ASJC Scopus subject areas

  • Biochemistry
  • Behavioral Neuroscience
  • Pharmacology


Dive into the research topics of 'Growth hormone release inhibiting hormone: Neuropharmacological studies'. Together they form a unique fingerprint.

Cite this